Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer

Published:2023-08-02 Issue: Volume: Page:
ISSN:0163-4984
Container-title:Biological Trace Element Research
language:en
Short-container-title:Biol Trace Elem Res

Author:

Li Nan,Yu Kai,Huang Delun,Li Shu,Zeng Dingyuan,Li Jingjing,Fan Li

Funder

Guangxi Medical high-level and sub backbone talents training “139” program

the Key Research and Development Program of Guangxi

Liuzhou Science and Technology Bureau Project

Guangxi Self-Finacing Research Program of Guangxi Region Health Commission

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Inorganic Chemistry,Clinical Biochemistry,General Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12011-023-03780-3.pdf

Reference38 articles.

1. Kurnit KC, Fleming GF, Lengyel E (2021) Updates and new options in advanced epithelial ovarian cancer treatment. Obstet Gynecol 137(1):108–121

2. Ovejero-Sanchez M, Gonzalez-Sarmiento R, Herrero AB (2023) DNA damage response alterations in ovarian cancer: from molecular mechanisms to therapeutic opportunities. Cancers (Basel) 15(2):448

3. Battistini C, Cavallaro U (2023) Patient-derived in vitro models of ovarian cancer: powerful tools to explore the biology of the disease and develop personalized treatments. Cancers (Basel) 15(2):368

4. van Zyl B, Tang D, Bowden NA (2018) Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment. Endocr Relat Cancer 25(5):R303–R318

5. Marrelli D, Ansaloni L, Federici O, Asero S, Carbone L, Marano L et al (2022) Cytoreductive surgery (CRS) and HIPEC for advanced ovarian cancer with peritoneal metastases: italian PSM oncoteam evidence and study purposes. Cancers (Basel) 14(23):6010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of a prognostic model for ovarian cancer based on a comprehensive bioinformatics analysis of cuproptosis-associated long non-coding RNA signatures;Heliyon;2024-08

2. Targeting cuproptosis for cancer therapy: Focus on the anti-tumor immune system;Cancer Pathogenesis and Therapy;2024-07

3. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer;Frontiers in Immunology;2024-02-09

4. LINC00861 Promotes Immune Response in the Tumor Microenvironment and Inhibits Prostate Cancer Tumor Growth by Regulating PD-L1;J BIOL REG HOMEOS AG;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3